Aquatic Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Aquatic Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-78,379	Closed	-$1.68M	–	1357
2026 Q1	$1.68M	Buy	78,379 +71,544	+1,047%	+$1.01M	0.05%	423
2025 Q4	$63.7K	Buy	+6,835	New	+$57.1K	﹤0.01%	1232

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aquatic Capital Management's DAWN Position: Q2 2026 in Review

Aquatic Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 78,379 shares — an estimated $1.68M sold.

Aquatic Capital Management first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $1.68M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Aquatic Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Aquatic Capital Management sold 78,379 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.68M.
Aquatic Capital Management first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
Aquatic Capital Management's Day One Biopharmaceuticals position peaked at $1.68M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.